MCP has been studied extensively in the context of autoimmune diseases, infections, and cancer. Mutations in the MCP gene have been linked to atypical hemolytic uremic syndrome (aHUS), a condition characterized by excessive activation of the complement system. Furthermore, certain pathogens, such as Neisseria species, exploit MCP to evade the immune system, highlighting the protein's role in infection biology.
